After flagging death risks, FDA rescinds accelerated approval for TG Therapeutics’ Ukoniq
After flagging death risks, FDA rescinds accelerated approval for TG [...]
After flagging death risks, FDA rescinds accelerated approval for TG [...]
Regeneron’s cholesterol drug war heats up with lawsuit over Amgen’s [...]
Former AstraZeneca exec charged with insider trading in Daiichi Sankyo’s [...]
Sanofi and Regeneron’s pipeline-in-a drug Dupixent nabs priority review for [...]
Moderna CEO pledges to donate most of his $4B fortune: [...]
Fraudster in Gilead’s counterfeiting case gets prison sentence in a [...]
Fierce Pharma Asia—J&J, Legend’s new CAR-T data; Junshi’s antiviral tops [...]
GSK’s ViiV to work with Medicines Patent Pool, generic manufacturers [...]
Pfizer and Moderna rapidly falling out of favor as Americans’ [...]
PharmaTher fleshes out ketamine delivery portfolio with deal for on-body [...]